Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Exchange | Industry | Zen Score | Market Cap | Price | 1d % | EBITDA | P/E | D/E |
|---|---|---|---|---|---|---|---|---|---|---|
| FENC | FENNEC PHARMACEUTICALS INC | NASDAQ | Biotechnology | $192.35M | $7.04 | -1.12% | $8.10M | 78.22x | 21.96 | |
| TGTX | TG THERAPEUTICS INC | NASDAQ | Biotechnology | $2.55B | $16.48 | -5.40% | $53.85M | 56.83x | 1.33 | |
| SRPT | SAREPTA THERAPEUTICS INC | NASDAQ | Biotechnology | $12.42B | $131.38 | -1.02% | $91.13M | 320.44x | 2.36 | |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | NASDAQ | Biotechnology | $1.65B | $29.03 | -0.96% | $237.47M | 12.35x | 0.64 | |
| INCY | INCYTE CORP | NASDAQ | Biotechnology | $12.82B | $57.10 | 0.42% | $1.11B | 17.15x | 0.32 | |
| MNKD | MANNKIND CORP | NASDAQ | Biotechnology | $1.25B | $4.59 | 0.00% | $45.65M | 114.75x | -3.09 | |
| CPRX | CATALYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | $1.95B | $16.49 | 0.55% | $122.26M | 27.48x | 0.15 | |
| HALO | HALOZYME THERAPEUTICS INC | NASDAQ | Biotechnology | $5.69B | $44.71 | -1.50% | $495.45M | 18.25x | 9.36 | |
| RPRX | ROYALTY PHARMA PLC | NASDAQ | Biotechnology | $16.29B | $27.27 | -2.19% | $983.33M | 15.23x | 0.64 | |
| GMAB | GENMAB A | NASDAQ | Biotechnology | $19.82B | $29.98 | 1.11% | N/A | 24.96x | 0.13 | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | NASDAQ | Biotechnology | $14.73B | $77.56 | 0.77% | $359.85M | 71.16x | 0.36 | |
| CORT | CORCEPT THERAPEUTICS INC | NASDAQ | Biotechnology | $2.92B | $28.09 | 2.00% | $122.89M | 24.43x | 0.20 | |
| PBYI | PUMA BIOTECHNOLOGY INC | NASDAQ | Biotechnology | $197.54M | $4.10 | -7.14% | $41.45M | 12.41x | 3.20 | |
| JAZZ | JAZZ PHARMACEUTICALS PLC | NASDAQ | Biotechnology | $6.87B | $108.99 | -1.36% | $1.16B | 20.84x | 2.06 | |
| TECH | BIO-TECHNE CORP | NASDAQ | Biotechnology | $13.21B | $83.81 | 1.16% | $354.14M | 65.99x | 0.35 | |
| BNTX | BIONTECH SE | NASDAQ | Biotechnology | $21.54B | $90.61 | -2.55% | $397.96M | 175.60x | 0.12 | |
| EXEL | EXELIXIS INC | NASDAQ | Biotechnology | $6.09B | $20.91 | -1.51% | $312.76M | 32.67x | 0.32 | |
| MDXG | MIMEDX GROUP INC | NASDAQ | Biotechnology | $1.15B | $7.80 | -1.14% | $50.76M | 15.00x | 0.42 | |
| REGN | REGENERON PHARMACEUTICALS INC | NASDAQ | Biotechnology | $108.23B | $982.29 | 1.48% | $4.55B | 27.20x | 0.27 | |
| UTHR | UNITED THERAPEUTICS CORP | NASDAQ | Biotechnology | $12.16B | $274.26 | 0.75% | $1.49B | 12.27x | 0.22 | |
| NVO | NOVO NORDISK A S | NYSE | Biotechnology | $594.82B | $131.89 | -0.86% | $17.67B | 45.91x | 2.02 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.